LACI TARRANT: Open Payments
NPI 1417524372 · CABOT, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$971 in 42 payments from 7 companies in 2025. Trend: 2023 $201 · 2024 $420 · 2025 $971
Food & beverage: $971
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $391 |
| Vanda Pharmaceuticals Inc. | 7 | $253 |
| AstraZeneca Pharmaceuticals LP | 8 | $170 |
| Lilly USA, LLC | 4 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Amgen Inc. | 2 | $29 |
| Lundbeck LLC | 1 | $24 |
Products named: VRAYLAR, FANAPT, HETLIOZ, BREZTRI, AIRSUPRA, MOUNJARO, CAPLYTA, OTEZLA.
Industry payments across AR — which companies pay providers there.
